BlueCrest Capital Management Ltd Grows Holdings in Varian Medical Systems, Inc. (VAR)

BlueCrest Capital Management Ltd grew its holdings in Varian Medical Systems, Inc. (NYSE:VAR) by 78.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,264 shares of the medical equipment provider’s stock after purchasing an additional 9,319 shares during the quarter. BlueCrest Capital Management Ltd’s holdings in Varian Medical Systems were worth $2,194,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Manchester Capital Management LLC lifted its stake in Varian Medical Systems by 16.5% in the 2nd quarter. Manchester Capital Management LLC now owns 1,057 shares of the medical equipment provider’s stock worth $109,000 after purchasing an additional 150 shares in the last quarter. Parallel Advisors LLC lifted its stake in Varian Medical Systems by 16.7% in the 1st quarter. Parallel Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock worth $113,000 after purchasing an additional 176 shares in the last quarter. Pacer Advisors Inc. lifted its stake in Varian Medical Systems by 3.1% in the 1st quarter. Pacer Advisors Inc. now owns 1,815 shares of the medical equipment provider’s stock worth $165,000 after purchasing an additional 55 shares in the last quarter. Penserra Capital Management LLC lifted its stake in Varian Medical Systems by 13.0% in the 2nd quarter. Penserra Capital Management LLC now owns 1,820 shares of the medical equipment provider’s stock worth $187,000 after purchasing an additional 210 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its stake in Varian Medical Systems by 0.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,912 shares of the medical equipment provider’s stock worth $197,000 after purchasing an additional 11 shares in the last quarter. 99.28% of the stock is currently owned by institutional investors and hedge funds.

In other Varian Medical Systems news, Director R Andrew Eckert sold 5,651 shares of the stock in a transaction that occurred on Friday, October 6th. The shares were sold at an average price of $102.39, for a total transaction of $578,605.89. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Dow R. Wilson sold 15,059 shares of the stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $96.48, for a total transaction of $1,452,892.32. Following the transaction, the insider now directly owns 81,835 shares in the company, valued at approximately $7,895,440.80. The disclosure for this sale can be found here. Insiders have sold 58,486 shares of company stock worth $5,960,501 in the last three months. Insiders own 0.91% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “BlueCrest Capital Management Ltd Grows Holdings in Varian Medical Systems, Inc. (VAR)” was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://ledgergazette.com/2017/10/11/bluecrest-capital-management-ltd-grows-holdings-in-varian-medical-systems-inc-var.html.

A number of research analysts have weighed in on VAR shares. BidaskClub lowered shares of Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Zacks Investment Research lowered shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, July 13th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $100.00 price target on shares of Varian Medical Systems in a research report on Friday, September 1st. Robert W. Baird reaffirmed a “hold” rating and set a $99.00 price target on shares of Varian Medical Systems in a research report on Monday, August 28th. Finally, BTIG Research lowered shares of Varian Medical Systems from a “buy” rating to a “neutral” rating in a research report on Thursday, September 7th. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $94.94.

Shares of Varian Medical Systems, Inc. (NYSE VAR) opened at 101.05 on Wednesday. The stock’s 50 day moving average is $103.88 and its 200 day moving average is $99.26. Varian Medical Systems, Inc. has a 52-week low of $75.20 and a 52-week high of $107.87. The stock has a market cap of $9.28 billion, a price-to-earnings ratio of 33.26 and a beta of 0.56.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, July 26th.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Manchester Capital Management LLC lifted its stake in Varian Medical Systems by 16.5% in the 2nd quarter. Manchester Capital Management LLC now owns 1,057 shares of the medical equipment provider’s stock worth $109,000 after purchasing an additional 150 shares in the last quarter. Parallel Advisors LLC lifted its stake in Varian Medical Systems by 16.7% in the 1st quarter. Parallel Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock worth $113,000 after purchasing an additional 176 shares in the last quarter. Pacer Advisors Inc. lifted its stake in Varian Medical Systems by 3.1% in the 1st quarter. Pacer Advisors Inc. now owns 1,815 shares of the medical equipment provider’s stock worth $165,000 after purchasing an additional 55 shares in the last quarter. Penserra Capital Management LLC lifted its stake in Varian Medical Systems by 13.0% in the 2nd quarter. Penserra Capital Management LLC now owns 1,820 shares of the medical equipment provider’s stock worth $187,000 after purchasing an additional 210 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its stake in Varian Medical Systems by 0.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,912 shares of the medical equipment provider’s stock worth $197,000 after purchasing an additional 11 shares in the last quarter. 99.28% of the stock is currently owned by institutional investors and hedge funds.

In other Varian Medical Systems news, Director R Andrew Eckert sold 5,651 shares of the stock in a transaction that occurred on Friday, October 6th. The shares were sold at an average price of $102.39, for a total transaction of $578,605.89. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Dow R. Wilson sold 15,059 shares of the stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $96.48, for a total transaction of $1,452,892.32. Following the transaction, the insider now directly owns 81,835 shares in the company, valued at approximately $7,895,440.80. The disclosure for this sale can be found here. Insiders have sold 58,486 shares of company stock worth $5,960,501 in the last three months. Insiders own 0.91% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “BlueCrest Capital Management Ltd Grows Holdings in Varian Medical Systems, Inc. (VAR)” was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://ledgergazette.com/2017/10/11/bluecrest-capital-management-ltd-grows-holdings-in-varian-medical-systems-inc-var.html.

A number of research analysts have weighed in on VAR shares. BidaskClub lowered shares of Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Zacks Investment Research lowered shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, July 13th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $100.00 price target on shares of Varian Medical Systems in a research report on Friday, September 1st. Robert W. Baird reaffirmed a “hold” rating and set a $99.00 price target on shares of Varian Medical Systems in a research report on Monday, August 28th. Finally, BTIG Research lowered shares of Varian Medical Systems from a “buy” rating to a “neutral” rating in a research report on Thursday, September 7th. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $94.94.

Shares of Varian Medical Systems, Inc. (NYSE VAR) opened at 101.05 on Wednesday. The stock’s 50 day moving average is $103.88 and its 200 day moving average is $99.26. Varian Medical Systems, Inc. has a 52-week low of $75.20 and a 52-week high of $107.87. The stock has a market cap of $9.28 billion, a price-to-earnings ratio of 33.26 and a beta of 0.56.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.09. The business had revenue of $662.40 million for the quarter, compared to the consensus estimate of $663.86 million. Varian Medical Systems had a net margin of 9.50% and a return on equity of 24.70%. The company’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.00 earnings per share. On average, equities analysts expect that Varian Medical Systems, Inc. will post $3.93 earnings per share for the current fiscal year.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply